PH12016501529B1 - Internal liquid agent - Google Patents
Internal liquid agentInfo
- Publication number
- PH12016501529B1 PH12016501529B1 PH12016501529A PH12016501529A PH12016501529B1 PH 12016501529 B1 PH12016501529 B1 PH 12016501529B1 PH 12016501529 A PH12016501529 A PH 12016501529A PH 12016501529 A PH12016501529 A PH 12016501529A PH 12016501529 B1 PH12016501529 B1 PH 12016501529B1
- Authority
- PH
- Philippines
- Prior art keywords
- liquid agent
- internal liquid
- inhibited
- pigment
- caused
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title abstract 3
- QNVKOSLOVOTXKF-UHFFFAOYSA-N 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;hydron;chloride Chemical compound Cl.NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1 QNVKOSLOVOTXKF-UHFFFAOYSA-N 0.000 abstract 2
- 229960000985 ambroxol hydrochloride Drugs 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 abstract 2
- 239000000049 pigment Substances 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 229960005174 ambroxol Drugs 0.000 abstract 1
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 abstract 1
- 235000019658 bitter taste Nutrition 0.000 abstract 1
- 238000002845 discoloration Methods 0.000 abstract 1
- 229940074391 gallic acid Drugs 0.000 abstract 1
- 235000004515 gallic acid Nutrition 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014028361 | 2014-02-18 | ||
| PCT/JP2015/054207 WO2015125757A1 (ja) | 2014-02-18 | 2015-02-17 | 内服液剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PH12016501529A1 PH12016501529A1 (en) | 2017-02-06 |
| PH12016501529B1 true PH12016501529B1 (en) | 2017-02-06 |
Family
ID=53878259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12016501529A PH12016501529B1 (en) | 2014-02-18 | 2016-08-03 | Internal liquid agent |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP6372559B2 (ja) |
| PH (1) | PH12016501529B1 (ja) |
| WO (1) | WO2015125757A1 (ja) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3949184B2 (ja) * | 1995-06-13 | 2007-07-25 | テイコクメディックス株式会社 | 塩酸アンブロキソール水性液剤 |
| JP2000007561A (ja) * | 1998-06-18 | 2000-01-11 | Nissho Corp | 塩酸アンブロキソール水溶液製剤 |
| US20050075403A1 (en) * | 2003-10-02 | 2005-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol for the treatment of inflammation in the pharynx |
| ITMI20032463A1 (it) * | 2003-12-16 | 2005-06-17 | Advance Holdings Ltd | Soluzione acquosa concentrata a base di ambroxolo |
| DE102004021992A1 (de) * | 2004-05-03 | 2005-11-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Topische Zubereitung enthaltend Ambroxol |
-
2015
- 2015-02-17 JP JP2016504098A patent/JP6372559B2/ja active Active
- 2015-02-17 WO PCT/JP2015/054207 patent/WO2015125757A1/ja active Application Filing
-
2016
- 2016-08-03 PH PH12016501529A patent/PH12016501529B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6372559B2 (ja) | 2018-08-15 |
| PH12016501529A1 (en) | 2017-02-06 |
| JPWO2015125757A1 (ja) | 2017-03-30 |
| WO2015125757A1 (ja) | 2015-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017011972A2 (pt) | derivados de azabicicloctano como agonistas de fxr para uso no tratamento de doenças hepáticas e gastrintestinais | |
| BR112016018555A8 (pt) | Ciclopropilaminas como inibidores de lsd1, seu uso, composição farmacêutica que os compreende e método de inibição de lsd1 | |
| BR112016018062A2 (pt) | compostos terapêuticos, composição farmacêutica e usos | |
| EP3102291A4 (en) | Progranulin (pgrn) and its derivatives for diagnosis and treatment of lysosomal storage diseases | |
| BR112016025396A2 (pt) | derivados de heterociclil-butanamida | |
| IL288777A (en) | Combinations for tumor treatment using quiescent cell targeting and egfr inhibitors | |
| EP3408254A4 (en) | SALTS OF 5-AMINOLÄVULINIC ACID AND DERIVATIVES | |
| BR112017008481A2 (pt) | composto antimicótico | |
| EP3186371A4 (en) | Administration of kynurenine depleting enzymes for tumor therapy | |
| EP3515559A4 (en) | COMPOSITIONS AND METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION AND TREATMENT OF AML USING USP10 BIOMARKERS AND MODULATORS | |
| BR112016028316A2 (pt) | composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento | |
| EP3355901A4 (en) | NOVEL EXTRACTS OF POLYGONUM CUSPIDATUM AND THEIR USE AS PHOTODYNAMIC INACTIVATION AGENTS | |
| BR112017008097A2 (pt) | método para tratar condições oculares | |
| BR112015024703A2 (pt) | formulação farmacêutica, método de tratamento e/ou prevenção de restenose e kit para o tratamento e/ou prevenção de restenose | |
| ECSP16086196A (es) | Sales farmacéuticamente aceptables de enantiomeros de pirlindole para uso en medicina | |
| EP3193870A4 (en) | Treatment of neurodegenerative diseases with combination of laquinimod and fingolimod | |
| EA201691796A1 (ru) | П-замещенные асимметричные мочевины и их применение в медицине | |
| MX2018003802A (es) | Formulacion de hipericina para el diagnostico fotodinamico. | |
| HK1257666A1 (zh) | 使用pm20d1和n-脂化氨基酸來識別、評估、預防和治療代謝紊亂的方法 | |
| PH12016501529B1 (en) | Internal liquid agent | |
| EP3235808A4 (en) | Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same | |
| DOP2016000325A (es) | Compuestos, composición farmacéutica y su uso en el tratamiento de enfermedades neurodegenerativas | |
| EA201501130A1 (ru) | Офтальмологическая фармацевтическая композиция | |
| EA201692367A1 (ru) | Сироп от кашля, содержащий амброксола гидрохлорид | |
| TR201618030T2 (tr) | Tadı düzeltilmiş parasetamol formülasyonları. |